About Index Trending news
Analyze
Top 50 Pricing
Fab'entech

Fab'entech

Work at Fab'entech? Add yourself to this profile

Fab'entech

#Biopharmaceutical company specialized in passive immunotherapy based on specific polyclonal immunoglobulins [F(ab')2] against emerging #infectiousdiseases.

Elsewhere

Alexa global traffic share

Twitter followers

Latest funding
Venture capital (Series A)
$4,128,628
Employees

Team size

10+

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Fab'entech makes some noise.